When Mounjaro Stops Working: What's Actually Going On

You've been doing everything right, and the scales haven't moved in weeks

It's a genuinely dispiriting moment. You started Mounjaro, the appetite suppression felt real, the weight came off, and then, at some dose or some month, progress ground to a halt. Before assuming the medicine has failed you, it's worth knowing that this happens to a significant proportion of people on tirzepatide, and it is expected biology rather than a personal failure.

The body is not a passive recipient of a medicine. As weight drops, your resting energy requirements fall too, your metabolism recalibrates to defend a new set point. This is sometimes called metabolic adaptation, and it happens independently of which medicine you take. A 15% reduction in body weight typically comes with a meaningful reduction in how many calories your body burns at rest. The medicine hasn't stopped working on the receptors; the target the medicine is hitting has simply shifted.

At the same time, gut hormone sensitivity can change over months of treatment. Tirzepatide activates both GIP and GLP-1 receptors, and while this dual action is clinically meaningful (the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body weight reductions of around 20–21% at the highest dose) that effect builds across months, not weeks. A plateau mid-titration is not the same as tirzepatide stopped working; it may simply mean you haven't reached the dose at which the medicine's full effect operates for you.

Worth checking: does Mounjaro stop working altogether, or is a plateau part of the expected arc?

The three things most likely behind a Mounjaro plateau

When patients tell our prescribers that tirzepatide has stopped working for them, the picture usually resolves into one of three patterns.

Dose hasn't kept pace with the body's adaptation. Mounjaro is titrated from 2.5mg upward through six strength options. The early doses settle your system; the higher doses are where the significant appetite and metabolic effects accrue for most people. If weight loss has slowed at 5mg or 7.5mg and there's clinical headroom to increase, a dose review is often the first conversation to have with your prescriber. The full Mounjaro treatment overview covers how the titration schedule is designed to work.

Lifestyle drift. After months on treatment, appetite suppression can feel like the new normal, which means it stops feeling like a medicine effect and more like just how things are. Small increases in portion size, reduced activity, or less protein in the diet can quietly erode progress without anyone noticing. This isn't a character flaw; it's what happens when effective appetite reduction stops feeling dramatic.

Plateau as a physiological end-point. For some people, the body reaches a weight it defends strongly regardless of intervention. This is genuinely difficult. It doesn't mean a different approach is impossible, but it does mean a frank conversation with a prescriber about whether the current plan is still working in the way it should. If you're wondering whether weight loss stalling on Mounjaro at a specific point is permanent, that question is worth putting directly to a clinician.

What a prescriber actually looks at when tirzepatide appears to stop working

A prescriber reviewing a plateau will typically ask about the dose you're currently on and how long you've been there, any changes to diet or activity (including things you might not think of as changes), whether you've had any illness, significant stress, or medication changes in the same period, and whether side effects are shaping your eating patterns in ways that work against progress.

Stress, poor sleep, and certain medications (including some antidepressants, steroids, and antipsychotics) can blunt weight-loss progress even on effective treatment. These are all things a prescriber needs to know. The NHS medicines page for tirzepatide lists the full range of drug interactions worth flagging at any review.

If you've recently transferred to a new provider or are considering doing so, it's also worth reading about what happens when you stop taking Mounjaro, since the circumstances around any break in treatment matter clinically.

On pricing: if cost is quietly shaping decisions about whether to continue, our Mounjaro cost page sets out what a private prescription typically includes, and what the market looks like now following changes to Lilly's UK list price in late 2025.

When stopping or pausing might be the right call

Not every plateau means pushing through. If you've been on the highest tolerated dose for several months with less than 5% total weight reduction from the start of treatment, NICE's published guidance on tirzepatide (TA1026) suggests that continuing treatment should be formally reviewed. That review is a clinical conversation, not an automatic stop.

There are also situations where a break from treatment is planned rather than a failure: surgery, pregnancy planning, or a period where injection-based treatment isn't practical. The considerations around those pauses are meaningfully different from a plateau mid-treatment, what happens when Mounjaro stops working versus when it's stopped on purpose aren't the same question.

If you're thinking about a fresh start with proper clinical oversight, or if your current prescriber hasn't reviewed your treatment in several months, start a free consultation with our prescribers and let a clinician look at the full picture. A real person reviews every consultation the same day, no automated routing.